(1) To investigate the effect of trimethoprim/sulphamethoxazole combination in the treatment of nongonococcal urethritis.
SULPHONAMIDES owe their antibacterial activity to their ability to inhibit the conversion of paraminobenzoic acid to dihydrofolic acid in the metabolic pathway leading to the synthesis of purine and ultimately of desoxyribonucleic acid (DNA) . Trimetho- prim* interferes with purine synthesis at the stage immediately following that affected by sulphonamides and inhibits the conversion of dihydrofolic acid to tetrahydrofolic acid. Hitchings and Busby (1961) reported that trimethoprim markedly potentiated the antibacterial activity of sulphonamides and Csonka and Knight (1967) reported the successful use of the trimethoprim /sulphamethoxazole combination in the treatment of gonorrhoea. No reports are so far available of the use of this combination in the treatment of non-gonococcal urethritis.
Present investigations
The present trials were conducted with two objects in view:
(1) To investigate the effect of trimethoprim/sulphamethoxazole combination in the treatment of nongonococcal urethritis.
(2) To determine the cure rate yielded by this drug combination in the treatment of gonorrhoea and to discover the stage at which gonococci disappeared from the urogenital and rectal secretions.
Pilot trials were conducted first using male cases only; subsequently a main trial was carried out in cases of gonorrhoea in both men and women.
(1) Non-gonococcal urethritis The study group was to have consisted of twenty consecutive cases of first attacks of non-gonococcal urethritis in white male patients. In fact only fourteen men entered the trial. Diagnosis was made on Received for publication August 18, 1969 *(1) Septrin-Burroughs Welicome.
(2) Bactrim-Roche. findings in urethral smears and cultures and 2-glass urine tests; cure was assessed on clinical improvement and on urethral smears and 2-glass urine test appearances.
Each patient was treated with 2 tablets of trimethoprim/sulphamethoxazole given twice daily for 4 days, each tablet containing 80 mg. trimethoprim and 400 mg. sulphamethoxazole.
RESULTS
Of the fourteen patients treated, two defaulted after the first day, and of the remaining twelve cases eight showed no improvement at all (Table I) . (Table III) . Of the 111 men who completed the observation period, 102 had gonococcal urethritis and nine had gonococcal proctitis (see Table III ).
In the main trial, of 111 fully-observed males, 106 were cured and five were held to be failures, giving an overall cure rate of 95-5 per cent. and a failure rate of 4-5 per cent. (Table III) .
Of the 42 female patients who were fully observed, 39 were cured and three were classed as failures, giving a cure rate of 93 per cent. and a failure rate of 7 per cent. Thus, of the total of 187 patients entering the main trial, 153 were known to have been fully treated and observed, and 145 of them were cured, so that the overall cure rate was 94-8 per cent. of 153 cases and the overall failure rate 5-2 per cent. (Table III) .
Gram-negative diplococci were no longer detectable on the second day in the urethral and rectal smears of 126 (95 4 per cent.) of the 132 males, i.e. after a single dose of 4 tablets of trimethoprim/ sulphamethoxazole (Table IV) .
Negative smears and cultures were obtained on the second day in 48 (94-1 per cent.) of the 51 women, i.e. after a single dose of 4 tablets of trimethoprim/ sulphamethoxazole (Table IV) . 
Discussion
Trimethoprim/sulphamethoxazole did not seem to be sufficiently effective in the treatment of non-specific urethritis to justify continuing with the pilot trial. It may be of some relevance that studies in vitro (Bushby, 1969) have shown that this drug combination has little or no effect on the growth of the 'T' strain mycoplasmas, even in concentrations much in excess of those possible in tissues under clinical conditions. Trimethoprim in combination with sulphamethoxazole in the treatment of gonococcal infection in both males and females, however, is a different proposition, and there is no doubt that this combination of drugs is very effective. In the small pilot trial the failure rate was 9 per cent., comparing well with the results of a single injection of 1 2 mega units of procaine penicillin. In the main trial there was a failure rate of only 4-5 per cent. of the 111 men who were followed-up and of 7 per cent. of the 42 
